Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis.
出版信息
J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1387. doi: 10.1136/jnnp.50.10.1387.
Abstract
摘要
相似文献
1
Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis.硫唑嘌呤治疗多发性硬化症的双盲对照试验。
J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1387. doi: 10.1136/jnnp.50.10.1387.
2
Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.硫唑嘌呤治疗多发性硬化症疗效的双盲对照随机研究。初步结果。
Ital J Neurol Sci. 1988 Feb;9(1):53-7. doi: 10.1007/BF02334408.
3
Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group.参与硫唑嘌呤多中心试验的多发性硬化症患者的组织相容性抗原。英国和荷兰多发性硬化症硫唑嘌呤试验组。
J Neurol Neurosurg Psychiatry. 1988 Mar;51(3):412-5. doi: 10.1136/jnnp.51.3.412.
4
5
Azathioprine in multiple sclerosis: the cons.硫唑嘌呤治疗多发性硬化症：反对观点
Neurology. 1988 Jul;38(7 Suppl 2):24-7.
6
A long-term double-blind controlled study on the effect of azathioprine in the treatment of multiple sclerosis.
Clin Neurol Neurosurg. 1988;90(1):25-8. doi: 10.1016/s0303-8467(88)80005-2.
7
A double blind study on azathioprine efficacy in multiple sclerosis: final report.一项关于硫唑嘌呤治疗多发性硬化症疗效的双盲研究：最终报告。
J Neurol. 1993 May;240(5):295-8. doi: 10.1007/BF00838165.
8
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.一项关于硫唑嘌呤联合或不联合甲泼尼龙治疗多发性硬化症的安慰剂对照、随机、双盲、可变剂量临床试验。
Neurology. 1989 Aug;39(8):1018-26. doi: 10.1212/wnl.39.8.1018.
9
Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.环孢素与硫唑嘌呤用于多发性硬化症的长期治疗——德国多中心研究结果
Ann Neurol. 1988 Jan;23(1):56-63. doi: 10.1002/ana.410230110.
10
[Current studies of the effects of immunosuppressive agents on multiple sclerosis].[免疫抑制剂对多发性硬化症影响的当前研究]
Ned Tijdschr Geneeskd. 1989 Jan 21;133(3):99-100.
引用本文的文献
1
Azathioprine for people with multiple sclerosis.硫唑嘌呤用于多发性硬化症患者。
Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.
2
Azathioprine for multiple sclerosis.硫唑嘌呤用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003982. doi: 10.1002/14651858.CD003982.pub2.
本文引用的文献
1
Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients.硫唑嘌呤治疗多发性硬化症。一项为期4年半、涵盖115名患者的有效性对照研究的最终结果。
J Neurol Sci. 1982 Jun;54(3):377-94. doi: 10.1016/0022-510x(82)90201-5.
2
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).评估多发性硬化症的神经功能损伤：扩展残疾状态量表（EDSS）
Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
3
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.进展性多发性硬化症的强化免疫抑制治疗。一项关于大剂量静脉注射环磷酰胺、血浆置换和促肾上腺皮质激素的随机三臂研究。
N Engl J Med. 1983 Jan 27;308(4):173-80. doi: 10.1056/NEJM198301273080401.
4
Long-term treatment of multiple sclerosis with azathioprine.硫唑嘌呤用于多发性硬化症的长期治疗。
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):124-6. doi: 10.1136/jnnp.36.1.124.
Zotero 插件